News | October 04, 2024
Lilly invests US$ 4.5 billion to create advanced research and manufacturing site
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
The inspection concluded with the issuance of a form 483 with five observations
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
At 10 years, more than one-third (34.0%) of patients with advanced melanoma were alive after treatment with KEYTRUDA, compared to 23.6% of patients treated with ipilimumab
Fluoxetine Tabs 60 mg approval solidifies the company's position in the molecule by complementing the recent approval in April 2024 for Fluoxetine 10 mg and 20 mg tablets and Fluoxetine capsules
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
Subscribe To Our Newsletter & Stay Updated
